Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/544273


Republic of Korea Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012


Description: Republic of Korea Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Republic of Korea cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices in Republic of Korea

Scope

- The report provides cardiovascular devices market information broken down into detailed categories and segments in Republic of Korea.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the cardiovascular devices market in Republic of Korea.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1 2
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 17
2.1 What Is This Report About? 17
3 Definitions of Markets Covered in the Report 18
3.1 Cardiovascular Devices 18
3.1.1 Pacemakers 18
3.1.2 Implantable Cardioverter Defibrillator (ICD) 18
3.1.3 Cardiac Resynchronisation Therapy 18
3.2 Interventional Cardiology 18
3.2.1 Coronary Stents 19
3.2.2 Cardiac Catheters 19
3.2.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters 19
3.3 Peripheral Vascular Devices 20
3.3.1 Peripheral Vascular Stents 20
3.3.2 Inferior Vena Cava Filter 20
3.3.3 PTA Balloon 20
3.3.4 Aortic Stent Graft 20
3.4 Cardiovascular Surgery 20
3.4.1 Beating Heart Systems 21
3.4.2 Cardiac Ablation Devices 21
3.4.3 Perfusion Systems 21
3.5 Cardiovascular Prosthetic Device 21
3.5.1 Prosthetic heart valves 21
3.5.2 Cardiac Assist Devices 21
3.6 Cardiovascular Monitoring and Diagnostic Devices 22
3.6.1 ECG Monitoring Equipment 22
3.6.2 ECG Stress Testing Systems 22
3.6.3 Holter Monitoring Systems 22
3.6.4 Event Monitoring Systems 22
4 Healthcare Sector Review 23
4.1 Healthcare Expenditure 23
4.2 Healthcare Infrastructure 26
4.3 Healthcare Policy 30
5 Regulation System 31
5.1 Medical Equipment Approval Process 31
5.1.1 Classification 31
5.1.2 Premarket Notification for Class I Devices 32
5.1.3 Pre-market Approval for Class II, III and IV Devices 32
5.1.4 License Fee 33
5.1.5 License Application Processing Duration 33
5.2 Post-market Surveillance 34
6 Pricing and Reimbursement 35
7 Distribution Structure 38
7.1 Distribution Structure 38
8 Cardiovascular Devices In Republic of Korea 39
8.1 Cardiovascular Devices Cross Country Comparison (2000-2012) 39
8.2 Cardiovascular Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012 40
8.3 Cardiovascular Devices, Republic of Korea, Category Volume (Units), 2000-2012 46
8.4 Cardiovascular Devices, Republic of Korea, Company Share (2006-2007) 51
9 Cardiac Rhythm Management In Republic of Korea 52
9.1 Cardiac Rhythm Management Overall Revenue (2000-2012) 52
9.1.1 Cardiac Resynchronisation Therapy Overall Revenues (2000-2012) 56
9.1.2 Implantable Cardioverter Defibrillator Overall Revenues (2000-2012) 58
9.1.3 Pacemaker Overall Revenues (2000-2012) 60
9.2 Cardiac Rhythm Management Overall Volume (2000-2012) 62
9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2012) 64
9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2012) 66
9.2.3 Pacemaker Overall Volume (2000-2012) 68
9.3 Cardiac Rhythm Management Average Price (2000-2012) 70
9.4 Cardiac Rhythm Management Distribution Share (2006-2007) 71
9.5 Cardiac Rhythm Management, Republic of Korea, Company Share (2006-2007) 72
10 Cardiovascular Monitoring and Diagnostic Devices In Republic of Korea 73
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2012) 73
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2012) 77
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2012) 79
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2006-2007) 80
10.5 Cardiovascular Monitoring and Diagnostic Devices, Republic of Korea, Company Share (2006-2007) 81
11 Cardiovascular Prosthetic Devices In Republic of Korea 82
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2012) 82
11.1.1 Cardiac Assist Devices, Overall Revenues (2000-2012) 83
11.1.2 Prosthetic Heart Valve Overall Revenues (2000-2012) 85
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2012) 88
11.2.1 Cardiac Assist Devices Overall Volume (2000-2012) 89
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2012) 92
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2012) 94
11.4 Cardiovascular Prosthetic Devices Distribution Share (2006-2007) 95
11.5 Cardiovascular Prosthetic Devices, Republic of Korea, Company Share (2006-2007) 96
12 Cardiovascular Surgery In Republic of Korea 97
12.1 Cardiovascular Surgery Overall Revenue (2000-2012) 97
12.1.1 Perfusion Disposables Overall Revenues (2000-2012) 101
12.2 Cardiovascular Surgery Overall Volume (2000-2012) 103
12.2.1 Perfusion Disposables Overall Volume (2000-2012) 104
12.3 Cardiovascular Surgery Average Price (2000-2012) 106
12.4 Cardiovascular Surgery Distribution Share (2006-2007) 107
12.5 Cardiovascular Surgery, Republic of Korea, Company Share (2006-2007) 108
13 Electrophysiology In Republic of Korea 109
13.1 Electrophysiology Overall Revenue (2000-2012) 109
13.2 Electrophysiology Overall Volume (2000-2012) 111
13.3 Electrophysiology Average Price (2000-2012) 112
13.4 Electrophysiology Distribution Share (2006-2007) 113
14 Interventional Cardiology In Republic of Korea 114
14.1 Interventional Cardiology Overall Revenue (2000-2012) 114
14.1.1 Cardiac Catheter Overall Revenues (2000-2012) 118
14.1.2 Coronary Stent Overall Revenues (2000-2012) 120
14.1.3 PTCA Balloon Overall Revenues (2000-2012) 121
14.2 Interventional Cardiology Overall Volume (2000-2012) 124
14.2.1 Cardiac Catheter Overall Volume (2000-2012) 128
14.2.2 Coronary Stent Overall Volume (2000-2012) 130
14.2.3 PTCA Balloon Overall Volume (2000-2012) 132
14.3 Interventional Cardiology Average Price (2000-2012) 134
14.4 Interventional Cardiology Distribution Share (2006-2007) 136
14.5 Interventional Cardiology, Republic of Korea, Company Share (2006-2007) 137
15 Peripheral Vascular Devices In Republic of Korea 138
15.1 Peripheral Vascular Devices Overall Revenue (2000-2012) 138
15.2 Peripheral Vascular Devices Overall Volume (2000-2012) 142
15.3 Peripheral Vascular Devices Average Price (2000-2012) 146
15.4 Peripheral Vascular Devices Distribution Share (2006-2007) 147
15.5 Peripheral Vascular Devices, Republic of Korea, Company Share (2006-2007) 148
16 Cordis Corporation Company Profile 149
16.1 Company Overview 149
16.2 Cordis Corporation Pipeline Products 150
16.2.1 Cordis Corporation Pipeline Products by Equipment Type 150
16.2.2 Cordis Corporation Pipeline Products by Development Stage 150
16.2.3 Cordis Corporation Pipeline Products by Therapy Area 151
16.2.4 Cordis Corporation Pipeline Products by Clinical Trials 151
16.2.5 Cordis Corporation Pipeline Products by News Summary 151
17 Boston Scientific Corporation Company Profile 152
17.1 Company Overview 152
17.2 Value Chain Analysis 152
17.2.1 Manufacturing 153
17.2.2 Product Development 153
17.2.3 Sales and Marketing 154
17.3 Boston Scientific Corporation Pipeline Products 155
17.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 155
17.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 156
17.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 157
17.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 158
17.3.5 Boston Scientific Corporation Pipeline Products by News Summary 159
18 Medtronic, Inc. Company Profile 162
18.1 Company Overview 162
18.2 Value Chain Analysis 163
18.2.1 Manufacturing 164
18.2.2 Product Development 164
18.2.3 Sales and Marketing 164
18.3 Medtronic, Inc. Pipeline Products 165
18.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 165
18.3.2 Medtronic, Inc. Pipeline Products by Development Stage 167
18.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 169
18.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 171
18.3.5 Medtronic, Inc. Pipeline Products by News Summary 172
19 Terumo Corporation Company Profile 173
19.1 Company Overview 173
19.2 Value Chain Analysis 173
19.2.1 Manufacturing 174
19.2.2 Product Development 174
19.2.3 Sales and Marketing 174
19.3 Terumo Corporation Pipeline Products 175
19.3.1 Terumo Corporation Pipeline Products by Equipment Type 175
19.3.2 Terumo Corporation Pipeline Products by Development Stage 175
19.3.3 Terumo Corporation Pipeline Products by Therapy Area 175
19.3.4 Terumo Corporation Pipeline Products by Clinical Trials 176
19.3.5 Terumo Corporation Pipeline Products by News Summary 176
20 Abbott Laboratories Company Profile 177
20.1 Company Overview 177
20.2 Value Chain Analysis 178
20.2.1 Manufacturing 179
20.2.2 Product Development 179
20.2.3 Sales and Marketing 180
20.2.4 Abbott Laboratories Pipeline Products by Equipment Type 180
20.2.5 Abbott Laboratories Pipeline Products by Development Stage 181
20.2.6 Abbott Laboratories Pipeline Products by Therapy Area 181
20.2.7 Abbott Laboratories Pipeline Products by Clinical Trials 181
20.2.8 Abbott Laboratories Pipeline Products by News Summary 181
21 St. Jude Medical Inc. Company Profile 182
21.1 Company Overview 182
21.2 Value Chain Analysis 183
21.2.1 Manufacturing 184
21.2.2 Product Development 184
21.2.3 Sales and Marketing 185
21.3 St. Jude Medical Inc. Pipeline Products 186
21.3.1 St. Jude Medical Inc. Pipeline Products by Equipment Type 186
21.3.2 St. Jude Medical Inc. Pipeline Products by Development Stage 187
21.3.3 St. Jude Medical Inc. Pipeline Products by Therapy Area 188
21.3.4 St. Jude Medical Inc. Pipeline Products by Clinical Trials 188
21.3.5 St. Jude Medical Inc. Pipeline Products by News Summary 189
22 Bionet Co.,Ltd. Company Profile 190
22.1 Company Overview 190
23 Mediana Co.,Ltd. Company Profile 191
23.1 Company Overview 191
24 Roche Diagnostics Korea Co., Ltd. Company Profile 192
24.1 Company Overview 192
25 Financial Deals Landscape 193
25.1 Equity Offerings 193
25.1.1 Meridian Completes Private Placement of $1.9 Million 193
25.2 Debt Offerings 194
25.2.1 BHK Completes Public Offering of $2.46 Million 194
25.3 Partnerships 195
25.3.1 St. Jude Medical and Conor Medsystems Signs Distribution Agreement 195
26 Appendix 196
26.1 Global Markets Direct Research Methodology 196
26.2 Coverage 197
26.3 Secondary Research 197
26.4 Primary Research 198
26.5 Models 198
26.6 Forecasts 199
26.7 Expert Panels 199
26.8 Currency Conversion 200
26.9 Contact Us 201
26.10 Disclaimer 201

Executive Summary

1.2 List of Figures
Figure 1: Healthcare Financing in Republic of Korea, 2007 24
Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006 25
Figure 3: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007 36
Figure 4: Medical Device Pricing System in Republic of Korea, 2007 37
Figure 5: Cardiovascular Devices Cross Country Comparison (2000-2012) 39
Figure 6: Cardiovascular Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012 40
Figure 7: Cardiovascular Devices, Republic of Korea, Portfolio Analysis, 2000-2012 41
Figure 8: Cardiovascular Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007 42
Figure 9: Cardiovascular Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012 44
Figure 10: Cardiovascular Devices, Republic of Korea, Category Volume (Units), 2000-2012 46
Figure 11: Cardiovascular Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2007 47
Figure 12: Cardiovascular Devices, Republic of Korea, Category Volume (Units), Forecast, 2007-2012 49
Figure 13: Cardiovascular Devices, Republic of Korea, Company Share (%), 2007 51
Figure 14: Cardiac Rhythm Management, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 52
Figure 15: Cardiac Rhythm Management, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 54
Figure 16: Cardiac Resynchronisation Therapy, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 56
Figure 17: Cardiac Resynchronisation Therapy, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 57
Figure 18: Implantable Cardioverter Defibrillator, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 58
Figure 19: Implantable Cardioverter Defibrillator, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 59
Figure 20: Pacemaker, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 60
Figure 21: Pacemaker, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 61
Figure 22: Cardiac Rhythm Management, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 62
Figure 23: Cardiac Rhythm Management, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 63
Figure 24: Cardiac Resynchronisation Therapy, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 64
Figure 25: Cardiac Resynchronisation Therapy, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 65
Figure 26: Implantable Cardioverter Defibrillator, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 66
Figure 27: Implantable Cardioverter Defibrillator, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 67
Figure 28: Pacemaker, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 68
Figure 29: Pacemaker, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 69
Figure 30: Cardiac Rhythm Management, Republic of Korea, Company Share (%), 2007 72
Figure 31: Cardiovascular Monitoring and Diagnostic Devices, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 73
Figure 32: Cardiovascular Monitoring and Diagnostic Devices, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 75
Figure 33: Cardiovascular Monitoring and Diagnostic Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 77
Figure 34: Cardiovascular Monitoring and Diagnostic Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 78
Figure 35: Cardiovascular Monitoring and Diagnostic Devices, Republic of Korea, Company Share (%), 2007 81
Figure 36: Cardiovascular Prosthetic Devices, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 82
Figure 37: Cardiovascular Prosthetic Devices, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 83
Figure 38: Cardiac Assist Devices, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 84
Figure 39: Cardiac Assist Devices, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 85
Figure 40: Prosthetic Heart Valve, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 86
Figure 41: Prosthetic Heart Valve, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 87
Figure 42: Cardiovascular Prosthetic Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 88
Figure 43: Cardiovascular Prosthetic Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 89
Figure 44: Cardiac Assist Devices, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 90
Figure 45: Cardiac Assist Devices, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 91
Figure 46: Prosthetic Heart Valve, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 92
Figure 47: Prosthetic Heart Valve, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 93
Figure 48: Cardiovascular Prosthetic Devices, Republic of Korea, Company Share (%), 2007 96
Figure 49: Cardiovascular Surgery, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 97
Figure 50: Cardiovascular Surgery, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 99
Figure 51: Perfusion Disposables, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 101
Figure 52: Perfusion Disposables, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 102
Figure 53: Perfusion Disposables, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 104
Figure 54: Perfusion Disposables, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 105
Figure 55: Cardiovascular Surgery, Republic of Korea, Company Share (%), 2007 108
Figure 56: Electrophysiology, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 109
Figure 57: Electrophysiology, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 110
Figure 58: Interventional Cardiology, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 114
Figure 59: Interventional Cardiology, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 116
Figure 60: Cardiac Catheter, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 118
Figure 61: Cardiac Catheter, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 119
Figure 62: Coronary Stent, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 120
Figure 63: Coronary Stent, Republic of Korea, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 121
Figure 64: PTCA Balloon, Republic of Korea, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 122
Figure 65: Interventional Cardiology, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 124
Figure 66: Interventional Cardiology, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 126
Figure 67: Cardiac Catheter, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 128
Figure 68: Cardiac Catheter, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 129
Figure 69: Coronary Stent, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 130
Figure 70: Coronary Stent, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 131
Figure 71: PTCA Balloon, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2000-2007 132
Figure 72: PTCA Balloon, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2007-2012 133
Figure 73: Interventional Cardiology, Republic of Korea, Company Share (%), 2007 137
Figure 74: Peripheral Vascular Devices, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007 138
Figure 75: Peripheral Vascular Devices, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012 140
Figure 76: Peripheral Vascular Devices, Republic of Korea, Overall Volume (Units), Historic, 2000-2007 142
Figure 77: Peripheral Vascular Devices, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012 144
Figure 78: Peripheral Vascular Devices, Republic of Korea, Company Share (%), 2007 148
Figure 79: Boston Scientific Corporation Value Chain Analysis 152
Figure 80: Medtronic, Inc. Value Chain Analysis 163
Figure 81: Terumo Corporation Value Chain Analysis 173
Figure 82: Abbott Laboratories Value Chain Analysis 178
Figure 83: St. Jude Medical Inc. Value Chain Analysis 183
Figure 84: Global Markets Direct Methodology 196


Companies Mentioned Cordis Corporation Boston Scientific Corporation Medtronic, Inc. Terumo Corporation Abbott Laboratories St. Jude Medical Inc. Bionet Co.,Ltd. Mediana Co.,Ltd. Roche Diagnostics Korea Co., Ltd.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/544273

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 09:25:13
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Republic of Korea Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012
Web Address:
http://www.researchandmarkets.com/reports/544273
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,263.00
Electronic (PDF) - Site License €4,527.00
Electronic (PDF) - Enterprisewide €6,790.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 09:25:13

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)